MUSTANG BIO, INC. (MBIO) Operating income 2016–2025
MUSTANG BIO, INC. (MBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$2.4MFY2025 · since FY2016: -$11.4M → -$2.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.4M | +85.0% |
| FY2024 | -$16.2M | +67.0% |
| FY2023 | -$49.3M | +35.3% |
| FY2022 | -$76.2M | -14.1% |
| FY2021 | -$66.7M | -17.5% |
| FY2020 | -$56.8M | -23.8% |
| FY2019 | -$45.9M | -47.0% |
| FY2018 | -$31.2M | +1.8% |
| FY2017 | -$31.8M | -179.7% |
| FY2016 | -$11.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MBIO financial trends
MBIO RevenueMBIO Net incomeMBIO Net marginMBIO Gross profitMBIO Gross marginMBIO Operating marginMBIO Operating cash flowMBIO Free cash flowMBIO Capital expendituresMBIO Return on equityMBIO Stock buybacksMBIO Dividends paidMBIO Total assetsMBIO Total liabilitiesMBIO Shareholders’ equityMBIO overview →